Abstract
Purpose of Review
While traditionally encountered in ambulatory settings, bruxism occurs in patients with a variety of acute neurologic illnesses including encephalitis, intracerebral hemorrhage, traumatic brain injury, hypoxic-ischemic encephalopathy, and acute ischemic stroke. Untreated bruxism in acute neurologic illness can lead to tooth loss, difficulty in mouth care resulting in recurrent aspiration pneumonia, endotracheal tube dislodgement, and even tongue laceration or amputation. Inpatient clinicians should be aware of the etiologies and management strategies for bruxism secondary to acute neurologic illness.
Recent Findings
Management strategies for bruxism are varied and include pharmacologic and non-pharmacologic therapies in addition to onabotulinumtoxinA (BoNT-A).
Summary
Bruxism impacts patients with a variety of acute neurologic illnesses, and emerging evidence suggests successful and safe treatment strategies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Rugh JD, Harlan J. Nocturnal bruxism and temporomandibular disorders. Adv Neurol. 1988;49:329–41.
• Ella B, Ghorayeb I, Burbaud P, Guehl D. Bruxism in movement disorders: a comprehensive review. J Prosthodont 2017:599–605. Recent review of bruxism in movement disorders.
Dhanrajani PJ, Jonaidel O. Trismus: aetiology, differential diagnosis and treatment. Dent Update. 2002;29:88–92 94.
Kato T, Masuda Y, Yoshida A, Morimoto T. Masseter EMG activity during sleep and sleep bruxism. Arch Ital Biol. 2011;149:478–91.
Yi HS, Kim HS, Seo MR. Trial of oral metoclopramide on diurnal bruxism of brain injury. Ann Rehabil Med. 2013;37:871–4.
Kwak YT, Han IW, Lee PH, Yoon JK, Suk SH. Associated conditions and clinical significance of awake bruxism. Geriatr Gerontol Int. 2009;9:382–90.
Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil. 2008;35:476–94.
Clark GT, Ram S. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Dent Clin N Am. 2007;51:225–43 viii–ix.
İnan R, Şenel GB, Yavlal F, Karadeniz D, Gündüz A, Kızıltan ME. Sleep bruxism is related to decreased inhibitory control of trigeminal motoneurons, but not with reticulobulbar system. Neurol Sci. Springer-Verlag Italia s.r.l. 2017;38:75–81.
Feu D, Catharino F, Quintão CCA, Almeida MA d O. A systematic review of etiological and risk factors associated with bruxism. J Orthod. 2013;40:163–71.
Pratap-Chand R, Gourie-Devi M. Bruxism: its significance in coma. Clin Neurol Neurosurg. 1985;87:113–7.
Garrett AR, Hawley JS. SSRI-associated bruxism: a systematic review of published case reports. Neurol Clin Pract. 2018;8:135–41.
Ohrbach R, Michelotti A. The role of stress in the etiology of oral parafunction and myofascial pain. Oral Maxillofac Surg Clin North Am. 2018;30:369–79.
Mohamed SE, Christensen LV, Penchas J. A randomized double-blind clinical trial of the effect of amitriptyline on nocturnal masseteric motor activity (sleep bruxism). Cranio. Maney Publishing. 1997;15:326–32.
Guaita M, Högl B. Current treatments of bruxism. Curr Treat Options Neurol. 2016;18(2):10.
Kobal F, Baqer A, Shanthini Singaram J. Botulinum toxin A for spastic trismus due to brain stem encephalitis in a pediatric intensive care setting: a unique case report. J Pediatr Intensive Care. Georg Thieme Verlag KG. 2018;07:216–8.
Cohen SG, Quinn PD. Facial trismus and myofascial pain associated with infections and malignant disease. Oral Surg Oral Med Oral Pathol. 1988;65:538–44.
Urriola N, Soosapilla K, Drummond J, Thieben M. Fulminant thymomatous AMPAR-antibody limbic encephalitis with hypertonic coma, bruxism, anisoelectric electroencephalogram and temporal cortical atrophy, with recovery.BMJ Case Rep. 2019;12(2).
Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7:1091–8.
Pollack IA, Cwik V. Bruxism following cerebellar hemorrhage. Neurology. 1989;39:1262.
Kesikburun S, Alaca R, Aras B, Tuǧcu I, Tan AK. Botulinum toxin injection for bruxism associated with brain injury: case report. J Rehabil Res Dev. Rehabilitation Research and Development Service. 2014;51:661–4.
El Maaytah M, Jerjes W, Upile T, Swinson B, Hopper C, Ayliffe P. Bruxism secondary to brain injury treated with botulinum toxin-A: a case report. Head Face Med. 2006;2:41.
Janati AB, Alghasab NS, Alghassab FS. Bruxism associated with anoxic encephalopathy: successful treatment with baclofen. Case Rep Dent. Hindawi Limited. 2013;2013:1–3.
Kim S-G, Kim M-J, Cha M-J, Cho S-J, Kwon K-H, Minn Y-K. Delayed-onset continuous bruxism with olivary hypertrophy after top of the basilar syndrome. J Clin Neurol. Korean Neurological Association. 2006;2:206.
Tan EK, Chan LL, Chang HM. Severe bruxism following basal ganglia infarcts: Insights into pathophysiology. J Neurol Sci. Elsevier. 2004;217:229–32.
• Jankovic J. An update on new and unique uses of botulinum toxin in movement disorders. Toxicon. 2018;147:84–8 Recent review of botulinum toxin in movement disorders.
Huynh N, Lavigne GJ, Lanfranchi PA, Montplaisir JY, De Champlain J. The effect of 2 sympatholytic medications - propranolol and clonidine - on sleep bruxism: experimental randomized controlled studies. Sleep. American Academy of Sleep Medicine. 2006;29:307–16.
Valiente López M, van Selms MKA, van der Zaag J, Hamburger HL, Lobbezoo F. Do sleep hygiene measures and progressive muscle relaxation influence sleep bruxism? Report of a randomised controlled trial. J Oral Rehabil. 2015;42:259–65.
Klasser GD, Greene CS. Oral appliances in the management of temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107:212–23.
van der Zaag J, Lobbezoo F, Wicks DJ, Visscher CM, Hamburger HL, Naeije M. Controlled assessment of the efficacy of occlusal stabilization splints on sleep bruxism. J Orofac Pain. 2005;19:151–8.
Harada T, Ichiki R, Tsukiyama Y, Koyano K. The effect of oral splint devices on sleep bruxism: a 6-week observation with an ambulatory electromyographic recording device. J Oral Rehabil. 2006;33:482–8.
Gagnon Y, Mayer P, Morisson F, Rompré PH, Lavigne GJ. Aggravation of respiratory disturbances by the use of an occlusal splint in apneic patients: a pilot study. Int J Prosthodont. 17:447–53.
Nikolopoulou M, Ahlberg J, Visscher CM, Hamburger HL, Naeije M, Lobbezoo F. Effects of occlusal stabilization splints on obstructive sleep apnea: a randomized controlled trial. J Orofac Pain. 2013;27:199–205.
Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. The effect of the catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Mov Disord. 1997;12:73–8.
Lavigne GJ, Soucy JP, Lobbezoo F, Manzini C, Blanchet PJ, Montplaisir JY. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol. 2001;24:145–9.
Pidcock FS, Wise JM, Christensen JR. Treatment of severe post-traumatic bruxism with botulinum toxin-A: case report. J Oral Maxillofac Surg. 2002;60:115–7.
Matak I, Lacković Z. Botulinum toxin A, brain and pain. Prog Neurobiol. 119–120:39–59.
Fernández-Núñez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: systematic review. Med Oral Patol Oral Cir Bucal. Medicina Oral S.L. 2019;24:e416–24.
•• Ondo WG, Simmons JH, Shahid MH, Hashem V, Hunter C, Jankovic J. Onabotulinum toxin-A injections for sleep bruxism. Neurology. Lippincott Williams and Wilkins; 2018;90:e559–64. Randomized controlled trial of onabotulinum toxin-A in treatment of sleep bruxism.
Ivanhoe CB, Lai JM, Francisco GE. Bruxism after brain injury: successful treatment with botulinum toxin-A. Arch Phys Med Rehabil. 1997;78:1272–3.
Guaita M, van Eendenburg C, Donaire A, Aparicio J, Setoain X, Bargalló N, et al. Ictal bruxism treated with temporal lobectomy. Sleep Med. Elsevier. 2015;16:1429–31.
Richter D, Saft C, Tönges L. Emergence of bruxism after reducing left pallidal stimulation in a patient with Huntington’s disease. Mov Disord Clin Pract. 2020;7:704–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Dr. Burke MD has nothing to disclose. Dr. Seitz has nothing to disclose. Mr. Aladesuru has nothing to disclose. Dr. Robbins reports serving on the Board of Directors of the American Headache Society and the New York State Neurological Society in non-remunerative positions. He receives book royalties from Wiley and serves editorial positions for Headache and Current Pain and Headache Reports. Dr. Ch’ang has nothing to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Secondary Headache
Rights and permissions
About this article
Cite this article
Burke, D.J., Seitz, A., Aladesuru, O. et al. Bruxism in Acute Neurologic Illness. Curr Pain Headache Rep 25, 41 (2021). https://doi.org/10.1007/s11916-021-00953-4
Accepted:
Published:
DOI: https://doi.org/10.1007/s11916-021-00953-4